HUM vs JAZZ · P/E 39, rev $117.76B vs P/E 1988, rev $4.07B
Humana Inc (HUM) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the HUM and JAZZ stock pages for the full models.
Not investment advice.